Abstract:Objective: Pancreatic cancer has a poor prognosis due to its high malignancy and rapid progression. The limited immunogenicity of pancreatic cancer (PAAD) contributes to its low responsiveness to immunotherapy, yet its underlying mechanism remains poorly understood. As a cancer promoting gene, Twist participates in EMT in various tumors and promotes tumor progression. The interplay between EMT and the tumor microenvironment (TME) emerges as a pivotal factor influencing tumor immunity and response to immunotherapy. Twist therefore has potential as a biomarker for gauging the outcome of tumour immunotherapy.This research aimed to assess the Twist's prognostic significance in PAAD and its relationship to immunotherapy response. Methods: In this research, transcriptional data and epigenetic alterations of Twist in pancreatic cancer, along with their impact on the prognosis of PAAD patients, were analyzed using databases. Functional enrichment analysis elucidated the biological role of Twist in PAAD. Subsequently, databases including CIBERSORT and TIDE were employed to investigate the association between Twist expression and immune cell infiltration, immune checkpoint genes, and immunotherapy sensitivity within the pancreatic cancer immune microenvironment.Paraffinized specimens from patients with pancreatic ductal adenocarcinoma confirmed by postoperative pathology were selected for Twist expression verification, and the difference was analyzed by Chi-square test; uncontaminated pancreatic cancer cell lines were used for Twist expression verification, and the differences were analyzed by Student t-test. Results: Twist mRNA expression was notably upregulated in PAAD, positively correlating with gene methylation levels. Analyses of Kaplan-Meier and Cox regression showed a correlation between better overall survival and lower Twist expression. Functional annotation indicated that Twist-associated differentially expressed genes (DEGs) were involved in EMT regulation and acute inflammation. High expression of Twist leads to a significant reduction in the infiltration of anti-tumor immune cells such as Monocytes, NKcellsactivated, and TcellsCD8, further supporting its creation of a typical immunosuppressive microenvironment in pancreatic cancer. Twist expression is positively correlated with the expression of HARVCR2, LAIR1, LGALS3 and other genes, which may be related to the treatment response to immune checkpoint inhibitors (ICIs). TIDE analysis predicts that patients with high expression of Twist will be insensitive to immunotherapy. Twist is significantly over-expressed in pancreatic cancer cell lines and tissues, and is negatively correlated with E-cadhrin expression, but positively correlated with N-cadherin,Snail, and ZEB1. Conclusion: High Twist expression in PAAD signifies a grim prognosis. Its elevated levels not only contribute to tumor progression through EMT induction but also exert regulatory control over the immune microenvironment, leading to immunosuppression and diminished effectiveness of immunotherapy.

Twist-1 Stimulates the Malignant Behaviors of Hydatidiform Mole via the PI3K/AKT Pathway

AKT-ions with a TWIST between EMT and MET.

Expression of Twist-1 promotes lymph node metastasis of gastric cancer cells

The expression of Twist and E -cadherin and its clinical significance in ovarian endometriosis

Roles of Cell Migration and Invasion Mediated by Twist in Endometriosis

A Novel Twist1/hsa-miR138-5p/caspase-3 Pathway Regulates Cell Proliferation and Apoptosis of Human Multiple Myeloma

MiR-526b Suppresses Cell Proliferation, Cell Invasion and Epithelial-Mesenchymal Transition in Breast Cancer by Targeting Twist1

Twist Mediates an Aggressive Phenotype in Human Colorectal Cancer Cells.

[Mismatch Repair Gene Promoter Methylation and Expression in Hydatidiform Moles and the Malignant Transformation].

Twist Regulation of EMT and Its Clinical Significance in Monitoring Circulating Tumor Cells and Evaluating Effects of Anticancer Drugs

Twist Promotes the Migration of Hepatocellular Carcinoma Cells

Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer

CSC‐3436 inhibits TWIST‐induced epithelial–mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma

Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms

Retracted: Cxcl12/Cxcr4 Axis Upregulates Twist to Induce Emt in Human Glioblastoma (retracted Article. See Vol. 54, Pg. 7553, 2017)

The prognostic significance of twist in pancreatic cancer and its role in cancer promotion through the regulation of the immune microenvironment and EMT mechanisms

Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.

[Expression and Significance of LMP2 and PPM1A in Gestational Trophoblastic Disease].

The Role of TWIST1 in Epithelial-Mesenchymal Transition and Cancers

Twist1 and Snail Link Hedgehog Signaling to Tumor-Initiating Cell-Like Properties and Acquired Chemoresistance Independently of ABC Transporters.

Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression